US2015132362A1PendingUtilityA1
Hemostatic sponge
Est. expiryJun 16, 2029(~2.9 yrs left)· nominal 20-yr term from priority
A61L 15/44A61L 26/00A61L 15/32A61L 15/64A61L 15/58A61L 15/325A61L 15/425A61L 2300/418A61L 2400/04A61L 15/26
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a hemostatic porous sponge comprising a matrix of a fibrous biomaterial and particles of a fluid absorbing, particulate material adhered to said matrix material, a method of producing these sponges and their use for wound healing.
Claims
exact text as granted — not AI-modified1 . A hemostatic porous sponge comprising a matrix of a fibrous biomaterial and particles of a fluid absorbing particulate material adhered to said matrix material.
2 . The sponge according to claim 1 , wherein said fibrous biomaterial comprises collagen.
3 . The sponge according to claim 1 , wherein said particulate material is a hemostatic material.
4 . The sponge according to claim 3 , wherein said particulate material is a cross-linked polymer.
5 . The sponge according to claim 3 , wherein said particulate material comprises gelatin, fibrin, collagen or any mixture thereof.
6 . The sponge according to claim 1 further comprising thrombin or a precursor of thrombin.
7 . The sponge according to claim 1 further comprising an adhesive layer.
8 . The sponge according to claim 7 , wherein said adhesive layer comprises a bioresorbable polymer.
9 . The sponge according to claim 7 , wherein the adhesive comprises a first cross-linkable component, a second cross-linkable component that cross-links with the first cross-linkable component under reaction enabling conditions.
10 . The sponge according to claim 9 , wherein said first and/or second cross-linkable component comprise PEG or a derivative thereof.
11 . The sponge according to claim 7 , wherein said adhesive comprises succinimidyl or maleimidyl and thiol or amino groups.
12 . The sponge according to claim 7 , wherein said adhesive layer is discontinuously coated on at least one side of the sponge.
13 . The sponge according to claim 1 being freeze-dried or air-dried.
14 . The sponge according to claim 1 comprising a supporting layer with greater tensile strength than the matrix material.
15 . The sponge according to claim 14 , wherein said supporting layer comprises a bioresorbable polymer.
16 . The sponge according to claim 14 , wherein said supporting layer comprises has a greater density than the matrix material.
17 . A method of manufacturing a hemostatic porous sponge comprising providing a fluid of a fibrous biomaterial and suspended particles of a fluid absorbing, particulate material, and drying said fluid with the suspended particles, thereby obtaining a hemostatic porous sponge comprising a matrix of a fibrous biomaterial and particles of a fluid absorbing, particulate material adhered to said matrix material.
18 . A hemostatic porous sponge obtainable by a method according to claim 17 .
19 . Method of treating an injury comprising administering a hemostatic porous sponge comprising a matrix of a fibrous biomaterial and a fluid absorbing, particulate material adhered to said matrix material to the site of injury.
20 . The method according to claim 19 , wherein said injury comprises a wound, a hemorrhage, damaged tissue and/or bleeding tissue.Join the waitlist — get patent alerts
Track US2015132362A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.